These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20237039)

  • 21. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial viability: heart failure perspective.
    Bock A; Estep JD
    Curr Opin Cardiol; 2019 Sep; 34(5):459-465. PubMed ID: 31233411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
    Lee KS; Marwick TH; Cook SA; Go RT; Fix JS; James KB; Sapp SK; MacIntyre WJ; Thomas JD
    Circulation; 1994 Dec; 90(6):2687-94. PubMed ID: 7994809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment.
    Zhang X; Liu XJ; Hu S; Schindler TH; Tian Y; He ZX; Gao R; Wu Q; Wei H; Sayre JW; Schelbert HR
    J Nucl Med; 2008 Aug; 49(8):1288-98. PubMed ID: 18632821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability.
    Landoni C; Lucignani G; Paolini G; Zuccari M; Galli L; Di Credico G; Rossetti C; Pelenghi S; Gilardi MC; Fazio F; Grossi A
    J Cardiovasc Surg (Torino); 1999 Jun; 40(3):363-72. PubMed ID: 10412921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.
    Castellani M; Colombo A; Giordano R; Pusineri E; Canzi C; Longari V; Piccaluga E; Palatresi S; Dellavedova L; Soligo D; Rebulla P; Gerundini P
    J Nucl Med; 2010 Dec; 51(12):1908-16. PubMed ID: 21078804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical impact of positron emission tomography by coincidence system with 18F-FDG on therapeutic decision-making of patients with ischemic cardiomyopathy after myocardial infarction].
    Felix RC; Correa PL; de Azevedo JC; Dohmann HF; Mesquita ET; Mesquita CT
    Arq Bras Cardiol; 2006 May; 86(5):337-45. PubMed ID: 16751937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M; Voth E; Schneider CA; Theissen P; Wagner R; Baer FM; Schicha H
    Magn Reson Imaging; 2004 Feb; 22(2):229-36. PubMed ID: 15010115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
    Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
    J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between collateral circulation and myocardial viability of
    Dong W; Li J; Mi H; Song X; Jiao J; Li Q
    Ann Nucl Med; 2018 Apr; 32(3):197-205. PubMed ID: 29380138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure.
    Mielniczuk LM; Birnie D; Ziadi MC; deKemp RA; DaSilva JN; Burwash I; Tang AT; Davies RA; Haddad H; Guo A; Aung M; Williams K; Ukkonen H; Beanlands RS
    Circ Cardiovasc Imaging; 2011 Jan; 4(1):59-66. PubMed ID: 21057116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome.
    Pagano D; Townend JN; Littler WA; Horton R; Camici PG; Bonser RS
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):791-9. PubMed ID: 9576212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with
    Xu D; Zhang J; Liu B; Fu D; Li J; Fan L
    Int J Cardiovasc Imaging; 2024 Apr; 40(4):887-895. PubMed ID: 38265540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
    Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
    J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
    Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
    J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.